background image

Fatty Liver Clinical Trials

Find clinical trials for Fatty Liver. Search for Fatty Liver clinical trials in different cities and states across the United States.

Filter
1
Active & Responsive

Siemens Biomarker Multi-modality

for
Fatty Liver, Hepatic Steatosis
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT07495332

Recruiting
Active & Responsive

Fibrosis Lessens After Metabolic Surgery

for
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD),
Location: Cleveland OH
Sponsor: Ali Aminian

Sex: All

Age: 18 - 70+

Code: NCT06374875

Recruiting
Active & Responsive

Congenital Muscle Disease Study of Patient and Family Reported Medical Information

for
Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency,
Location: Lakewood CA
Sponsor: Cure CMD

Sex: All

Age: 0+

Code: NCT01403402

Recruiting
Active & Responsive

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

for
Obesity, Non-Alcoholic Fatty Liver Disease,
Location: Columbia MO
Sponsor: Bettina Mittendorfer

Sex: All

Age: 18 - 70

Code: NCT06571474

Recruiting
Active & Responsive

Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease,
Location: Seattle WA
Sponsor: ContextVision AB

Sex: All

Age: 18 - 70+

Code: NCT07270601

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: New Bedford MA, New Haven CT, Manhasset NY, New York NY,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: South Dartmouth MA, New Haven CT, Manhasset NY,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase3, Recruiting
Active & Responsive

A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight

for
Overweight or Obesity and Elevated Liver Fat
Location: Glen Burnie MD, Miami Lakes FL, Gainesville FL,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07441252

Phase2, Recruiting
Active & Responsive

Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)

for
Hepatic Steatosis, NAFLD, Adolescent Obesity
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 13 - 18

Code: NCT05935826

Phase3, Recruiting
Active & Responsive

Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD

for
Metabolic Dysfunction-Associated Steatotic Liver Disease,
Location: Boardman OH
Sponsor: Seoul National University Hospital

Sex: All

Age: 18+

Code: NCT07192159

Recruiting